Dr. Nabil Dib - Cardiovascular and Stem Cell Consultants

Cardiovascular and Stem Cell Consultants - Homepage

Industry

Consultants: Our specialty in clinical and preclinical research provide the health care industry with a unique opportunity for collaboration. Dr. Dib has specialized degrees in investigational devices and clinical research from Harvard Medical School and Harvard School of Public Health. With over 10 years of experience, he has had an instrumental role in more than 50 preclinical and clinical trials. One of his major projects included the technological development of stem cell transplantation via catheter and which led to three Phase I clinical trials on stem cell therapy. Our consultants have expertise in autologous myoblasts, bone marrow cells and peripheral derived stem cells. There has been six years of preclinical research on animal models with healthy hearts and myocardial infarction where stem cells were delivered via catheter. We can also provide expertise in toxicology and translational research for both stem cells and devices. In addition, our staff can provide assistance in writing protocols and help in obtaining approval by the FDA for clinical trials as well as implementation of clinical trials.

Dr Nabil Dib ,MD, MSc,FACC

Director of Cardiovascular Research at Chandler Regional Medical Center and Mercy Gilbert Medical Center.

Director of Cardiovascular Cell Therapy, University of California San Diego

Director of Cardiovascular Stem Cell Consultants.
www.cardiostem.com

President of International Society of Cardiovascular Research
www.isctr.org

MEDICAL EDUCATION

Fellowship:
Interventional Cardiology, Harvard Medical School
Research, Harvard Medical School
General Cardiology, U of Wisconsin Milwaukee

Residency:
Internal Medicine, Tufts University

Undergraduate:
Medical Degree, Damascus University, Syria.